ADVANCING LEUKEMIA DIAGNOSTICS

Background

Medical progress

Leukemia is a malignant disease. But it is treatable and increasingly curable. Or more precisely: “The various forms of leukemia are,” because there are very different kinds of leukemia and lymphoma. And the various therapies developed by medical research are equally specific. In the last 10 years, knowledge about the diagnosis, prognosis and treatment has increased significantly.

Complex diagnostics

In view of this, it is very important that a comprehensive and timely diagnosis is made and the respective disease is correctly classified (according to the 2017 WHO classification). However, the diagnostics themselves are quite complex and based on a combination of very different methods: cytomorphology and cytochemistry, histology and immunohistology, immunophenotyping, traditional chromosome analysis, fluorescence in situ hybridization (FISH) and molecular genetic methods for the detection of changes in individual genes. For many patients, a combination of these methods is necessary and sensible.

Against this backdrop, there is an urgent need to establish and optimize diagnostic procedures.

The Goal

The best possible therapies for many

We have taken it upon ourselves to make the choice of the best possible therapy a standard by promoting and improving diagnostics. This should give the greatest possible number of patients with leukemias and lymphomas access to optimal and targeted treatment and achieve an increasing number of cures.

Overcoming complexity

The task is complex for the reasons described above. This is because, in addition to ensuring the correct diagnostics, it is also necessary to provide the various simultaneously required methods/equipment as well as the corresponding findings. And last but not least, understandable explanations for doctors and patients are needed. Furthermore, it must be ensured that the methods offered can be accredited. The timely and proper development of a reliable and suitable infrastructure that is available worldwide is an extensive task that requires intensive efforts. This is where our Foundation’s activities come into play.

To our Statutes

THE CREATION OF UNDERSTANDABLE FINDINGS FOR DOCTORS AND PATIENTS IS A DECISIVE STEP ON THE WAY TO THE RIGHT THERAPY. WE ARE ALSO WORKING ON THAT.

Prof. Dr. Dr. Torsten Haferlach, Founder

What we do

The Foundation’s own projects

We carry out projects with the following objectives:

  • Improvement of laboratory infrastructure by incorporating state-of-the-art software and artificial intelligence
  • Improvement and implementation of digital concepts and networking in leukemia diagnostics
  • Strengthening of diagnostic measures for the application of targeted treatment strategies (so-called targeted treatment, precision medicine)
  • Raising public interest in leukemia diagnostics

Scholarships

We award scholarships for research and development in the area of user-oriented routine diagnostics with the aim of implementation in daily practice.

Scholarship Guidelines

Third-party support

We generate and collect funds for institutions with the same objectives for the following purposes:

  • Implementation of specific projects in our field (worldwide with special consideration given to “emerging markets”)
  • Awarding of prizes for practical success or theoretical-preparatory work in our field
  • Establishment and funding of institutions dealing with routine diagnostics for forms of leukemia and lymphoma
  • Promotion of interdisciplinary cooperation, especially by means of digital structures, between institutions, also internationally

Board of Directors

THLDS_Vorstand_Christian_Peschel
Prof. Dr. Christian Peschel
München

Board of Trustees

THLDS_Kuratorium_Torsten_Haferlach
Prof. Dr. Dr. Torsten Haferlach
München
THLDS_Kuratorium_Andreas_Hochhaus
Prof. Dr. Andreas Hochhaus
Weimar
THLDS_Kuratorium_Wolf-K_Hofmann
Prof. Dr. Wolf-K. Hofmann
Mannheim
THLDS_Kuratorium_Ute_Berger
Dr. Ute Berger
Speyer
THLDS_Kuratorium_Jan_Geissler
Jan Geissler
München

Donations

You wish to support the foundation’s work? Our donation account is:

HypoVereinsbank

IBAN: DE9374 3200 7300 2778 2329
BIC/SWIFT: HYVEDEMM433

Purpose of payment line 1:
THLDS

Purpose of payment line 2:
Address of donor

Contact

We will gladly answer your questions or provide you with information on the Foundation.

Telephone: +49 (0)89 99015-0     Send an e-mail